Trafford General Hospital is a district general hospital in Davyhulme, Greater Manchester, England, managed by Manchester University NHS Foundation Trust.

There are 230 beds in Trafford General Hospital.

During the past decade, Trafford General Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Trafford General Hospital" #1 sponsor was "Manchester University NHS Foundation Trust" with 3 trials, followed by "Genzyme, a Sanofi Company" with 1 trials sponsored, "Newcastle-upon-Tyne Hospitals NHS Trust" with 1 trials sponsored, "Queen's Medical Center" with 1 trials sponsored and "Taunton and Somerset Hospital" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Trafford General Hospital" #1 collaborator was "Manchester University NHS Foundation Trust" with 1 trials as a collaborator, "Medacta International SA" with 1 trials as a collaborator, "University of Manchester" with 1 trials as a collaborator and "University of Salford" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Trafford General Hospital" are "Knee Osteoarthritis" (2 trials), "Lymphoma" (2 trials), "Osteoarthritis, Knee" (2 trials), "Acquired Brain Injury" (1 trials) and "Cartilage Damage" (1 trials). Many other conditions were trialed in "Trafford General Hospital" in a lesser frequency.

Most popular intervention types in "Trafford General Hospital" are "Drug" (4 trials), "Other" (4 trials), "Procedure" (3 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "fludarabine phosphate" (2 trials), "Conventional" (1 trials), "DNA methylation analysis" (1 trials), "Patient specific instrumentation" (1 trials) and "Phosphate Buffered Saline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Trafford General Hospital" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Trafford General Hospital". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Trafford General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Trafford General Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".